Press Releases

WINSTON-SALEM, N.C.--(BUSINESS WIRE)-- HanesBrands (NYSE: HBI), a leading global marketer of everyday basic apparel under world-class brands, today announced third-quarter 2018 results, including a $14 million charge related to a retailer bankruptcy that masks underlying performance. Third-quarter net sales increased 3 percent to $1.85 billion, and constant-currency organic sales, which increased for

DUBLIN--(BUSINESS WIRE)-- The "Production Monitoring Market by Component (Solutions and Services), Solution, Service (Professional and Managed), Organization Size, Industry (Process Manufacturing and Discrete Manufacturing), and Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's

BRISBANE, Australia--(BUSINESS WIRE)-- Johnson & Johnson Innovation announced the extension of the Johnson & Johnson Innovation Partnering Office at Queensland University of Technology (JJIPO @ QUT) for three years in collaboration with the Queensland State Government at the AusBiotech National Conference in Brisbane yesterday. The extension of the joint initiative between Johnson & Johns

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2018 and updated its guidance for full year 2018.

DUBLIN--(BUSINESS WIRE)-- The "Global Multi-layer blown films Market Analysis 2018 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis.

FORT MILL, S.C.--(BUSINESS WIRE)-- Domtar Corporation (NYSE: UFS) (TSX: UFS) today reported net earnings of $99 million ($1.57 per share) for the third quarter of 2018 compared to net earnings of $43 million ($0.68 per share) for the second quarter of 2018 and net earnings of $70 million ($1.11 per share) for the third quarter of 2017. Sales for the third quarter of 2018 were $1.4 billion.

DUBLIN--(BUSINESS WIRE)-- The "Global Military Battery Market Analysis 2018 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis.

MIDLAND, Mich. & WILMINGTON, Del.--(BUSINESS WIRE)-- DowDuPont™ (NYSE: DWDP) today announced the members of the future boards of directors of Dow, DuPont, and Corteva Agriscience™, establishing strong governance structures that will support the long-term value creation of each independent company. Jeff Fettig, executive chairman of DowDuPont, said, “The estab

MILPITAS, Calif.--(BUSINESS WIRE)-- ABBYY®, a global provider of content intelligent solutions and services, and

MIDLAND, Mich. & WILMINGTON, Del.--(BUSINESS WIRE)-- DowDuPont (NYSE: DWDP): Third Quarter Financial Highlights GAAP earnings per share from continuing operations was $0.21. Adjusted earnings1 per share increased 35 percent to $0.74, compared with pro forma adjusted earnings1 per share in the year-a

HONG KONG--(BUSINESS WIRE)-- OPPLE Lighting, the leading integrated lighting manufacturer, exhibited at the Hong Kong International Lighting Fair 2018 Autumn Edition in Hong Kong Convention and Exhibition Centre on Oct 27-30, 2018, featuring its smart lifestyle concept as well as scenario-based Bluetooth lighting solutions. This press release features multimedia. View the full release he

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2018. Mr. Kåre Schultz, Teva’s President and CEO, said, “I am very satisfied with our progress and we are meeting all our key targets. We received FDA approval for AJOVY™ in September for the preventive treatment of migraine and w

MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)-- Stratasys Ltd. (NASDAQ: SSYS) announced financial results for the third quarter of 2018. Q3 2018 Fina

TOKYO--(BUSINESS WIRE)-- The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.; together, the “Company”) announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury (TBI), met its primary endpoint. This STEMTRA study showed that TBI patients with chronic motor deficits treated with SB623 cells demonstrated a statistica

MINNEAPOLIS--(BUSINESS WIRE)-- Minnesota-based Osprey Medical Inc. (ASX:OSP) (Osprey or Company) today announces that it has entered into an agreement with Allan Gray, a leading investment management firm, to subscribe for approximately 64.5m CHESS Depositary Interests (CDIs) in the Company (representing approximately 32.3m shares of common stock) through the Australian Securities Exchange (ASX) a